From 2016 to 2022, 51.5% of children aged 4–5 years and 74.5% of children and adolescents aged 6–17 years received treatment in line with pediatric ADHD clinical practice guidelines, although ...

Table 1 Review of practice parameters and treatment guidelines for ADHD. Efforts at improving efficacy and effectiveness of psychosocial intervention for ADHD: what do we know and where do we go?

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that is commonly diagnosed in children and adolescents, but it can persist into ...

Medication and behavioral treatments are both widely used to treat ADHD. While medication is often the first-line treatment, patients who receive behavioral treatments—typically therapy, parent ...

The COVID-19 pandemic has had a significant impact on children and adults with ADHD. This case explores the effects long COVID has had on an adult patient with ADHD. This is the 5th installment of our ...

CNS stimulants vs nonstimulants may yield better clinical outcomes for adolescents and young adults with ADHD and comorbid depression.

Childhood use of the stimulant methylphenidate, the most commonly prescribed medication for attention-deficit/hyperactivity disorder (ADHD), is not associated with ...

New Zealanders with attention-deficit hyperactivity disorder (ADHD) will now have easier access to diagnosis and medication after the government changed prescribing rules. But there is still so much ...

The use of ADHD medication has increased notably in recent years, but its long-term effects in children have not been sufficiently studied, despite years of use. A recent population-based register ...

Medication and behavioral treatments are both widely used to treat ADHD. Medication is often the first-line treatment; however, some patients find it ineffective or difficult to tolerate, while others ...